Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
Eveline S.J.M. de Bont(Hôpital Saint-Michel), Nicolaas A. Bos(University Medical Center Groningen), Tiny Meeuwsen, Frank J.G. Scherpen, Jeroen E. J. Guikema(Amsterdam University Medical Centers), Edo Vellenga(University Medical Center Groningen), Willem A. Kamps(Pediatric Oncology Group)
PubMed
October 15, 2001
Cited by 59
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599